REVB
Revelation Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website revbiosciences.com
- Employees(FY) 6
- ISIN US76135L5075
Performance
-8.18%
1W
+5.76%
1M
-27.08%
3M
-90.04%
6M
-86.55%
YTD
-93.59%
1Y
Profile
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, urinary tract infection, sepsis, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease. It is also developing REVTx-99b, a treatment for food allergies; REVTx-99a, an anti-viral nasal drop solution for the potential prevention or treatment of respiratory viral infection; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, influenza A, influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
Technical Analysis of REVB 2024-05-10
Overview:
In analyzing the technical indicators for REVB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
- 2024-05-10 09:53
- 2024-05-10 04:52
- 2024-03-22 09:52
- 2024-03-22 04:15
- 2024-03-12 21:00
- 2024-03-11 21:00
- 2024-03-03 20:00
- 2024-02-12 20:00
- 2024-02-05 03:41
- 2024-01-31 19:27
Why Is Revelation Biosciences (REVB) Stock Down 62% Today?(Investorplace)
- 2024-01-31 17:00
- 2024-01-29 20:00
- 2024-01-28 19:26
Why Is Revelation Biosciences (REVB) Stock Up 61% Today?(Investorplace)
- 2024-01-22 20:00
- 2023-11-13 03:05
- 2023-10-11 21:00
- 2023-10-03 21:00
- 2023-10-01 21:00
- 2023-08-13 19:36
REVB Reports Solid Balance Sheet and Remains on Track(Yahoo Finance)
- 2023-08-11 04:10
- 2023-06-28 21:00
- 2023-06-21 22:24
REVB: REVB Looks Attractive Ahead of Trials(Yahoo Finance)
- 2023-06-12 04:15
- 2023-05-21 21:00
- 2023-03-30 05:42
- 2023-03-12 21:00
- 2023-03-05 20:00
- 2023-02-13 03:20
- 2023-02-08 20:42
- 2023-02-06 20:00
Page 1 of 2
previousnext